Clinical Trial Update: GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on GW572016 (lapatinib) for colorectal cancer patients who previously received 5-FU plus CPT-11 and/or oxaliplatin. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• GW572016 (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED